申请人:ISOBE Yoshiaki
公开号:US20120178743A1
公开(公告)日:2012-07-12
An antiallergic agent for topical administration containing an adenine compound of general formula (1):
[wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X
1
represents oxygen, sulfur, NR
1
(R
1
represents hydrogen or alkyl), or a single bond; Y
1
represents a single bond, alkylene, etc.; Y
2
represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q
1
and Q
2
represents —COOR
10
(wherein R
10
represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.
一种用于局部给药的抗过敏剂,包含一种通式(1)的腺嘌呤化合物:[其中环A代表一个6到10个成员的单环或双环芳香烃或一个5到10个成员的单环或双环芳香杂环,其中包含1到3个杂原子,选择自0到2个氮原子,0或1个氧原子和0或1个硫原子;n是0到2的整数;m是0到2的整数;R代表卤素,(未)取代的烷基等;X1代表氧,硫,NR1(R1代表氢或烷基)或单键;Y1代表单键,亚烷基等;Y2代表单键,亚烷基等;Z代表亚烷基;且Q1和Q2中的至少一个代表—COOR10(其中R10代表(未)取代的烷基等),等的药学上可接受的盐。